ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,275.38
0.54%
Dow Jones
38,686.32
1.51%
Gold vs US Dollar
2,327.355
0.00%
Brent Oil
81.295
0.00%
Bitcoin
67,671.59
0.28%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Quince Therapeutics Inc (QNCX) Share Price

QNCX Quince Therapeutics Inc

0.83
-0.0023 (-0.28%)
01 Jun 2024 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Quince Therapeutics Inc NASDAQ:QNCX NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.0023 -0.28 0.83 0.80 0.945 0.88 0.83 0.83 29,873 00:00:00   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Biological Pds,ex Diagnstics  -31.39M -0.7321 -1.13 35.58M
 Type  Size  Price  Time  Units 
 9 56 0.83 20:02:58 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore QNCX News
13/05/202412:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/05/202412:00BWQuince Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
06/05/202421:05BWQuince Therapeutics to Present at The Citizens JMP Life Sciences Conference
01/04/202412:00BWQuince Therapeutics Provides Business Update and Reports Fourth Quarter and Fiscal 2023 Financial Results
22/02/202412:00BWQuince Therapeutics Launches Scientific Advisory Board
15/02/202421:00EDGAR2Form 8-K - Current report
15/02/202412:00BWQuince Therapeutics Appoints Former Reata Pharmaceuticals Chief R&D Officer Dr. Rajiv Patni to its Board of Directors
Period
Draw mode
Data Downloads for QNCX

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Quince Therapeutics Inc Articles